Recombinant Human Deoxyribonuclease 1 [EPC]

16250 reported adverse events

Drugs of this class: DORNASE ALFA

These side effects are most commonly reported by patients taking drugs of the Recombinant Human Deoxyribonuclease 1 [EPC] class:

# Side effect Count
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2095
1 CYSTIC FIBROSIS 1418
2 HOSPITALISATION 1066
3 PNEUMONIA 1024
4 COUGH 889
5 DYSPNOEA 751
6 INFECTION 749
7 CONDITION AGGRAVATED 545
8 OFF LABEL USE 521
9 NO ADVERSE EVENT 518
See all common reactions for Recombinant Human Deoxyribonuclease 1 [EPC]

Drugs of the Recombinant Human Deoxyribonuclease 1 [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYSTIC FIBROSIS HEPATIC DISEASE 8 0.6154
1 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2095 0.4458
2 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 266 0.3415
3 CYSTIC FIBROSIS 1418 0.3132
4 CYSTIC FIBROSIS LUNG 32 0.3077
5 CYSTIC FIBROSIS RELATED DIABETES 27 0.3034
6 DISTAL INTESTINAL OBSTRUCTION SYNDROME 54 0.2443
7 SWEAT TEST ABNORMAL 6 0.1765
8 POSITIVE AIRWAY PRESSURE THERAPY 9 0.1552
9 INFECTIVE EXACERBATION OF BRONCHIECTASIS 28 0.1443
See all enriched reactions for Recombinant Human Deoxyribonuclease 1 [EPC]